NM_001144013.2:c.5039A>G
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001144013.2(RGPD3):c.5039A>G(p.Asn1680Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000806 in 1,611,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144013.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152112Hom.: 0 Cov.: 27 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 249308 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1459694Hom.: 0 Cov.: 40 AF XY: 0.00000689 AC XY: 5AN XY: 726156 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152230Hom.: 0 Cov.: 27 AF XY: 0.0000134 AC XY: 1AN XY: 74410 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5039A>G (p.N1680S) alteration is located in exon 21 (coding exon 21) of the RGPD3 gene. This alteration results from a A to G substitution at nucleotide position 5039, causing the asparagine (N) at amino acid position 1680 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at